Autoimmune Disorders
| Focus: | Autoimmune Disorders |
|---|---|
| Type: | database (supplied by e-mail as setup.exe file) |
| No. of deals: | 112 |
| No. of companies: | 133 |
| Years covered: | 1996 – 2011 |
| Price: | € 700 ex VAT (if applicable) |
| System requirements: | Windows 2000/Windows XP/Windows Vista / 7 |
| Publisher: | PharmaPlus Consultancy B.V. |
Are you about to enter deal negotiations for your autoimmune therapeutic?
Use PharmaDeal Financials Autoimmune Disorders to benchmark your next autoimmune deal
PharmaDeal Financials Autoimmune Disorders
- Deal specifics on more than 110 autoimmune deals
- Deal structure trends since 1996
- 90 different licensors
- All indications and compound classes including antibodies, kinase inhibitors, spingosine-1 modulators, RORgamma modulators and stem cells
- 46% early stage deals
- 26% antibody-related deals
- Milestones FDA-approval up to USD 45 million
- Research funding up to USD 581 million
- Equity from USD 0.375 million to USD 372 million
Each deal entry is categorized and searchable by licensor, licensee, indication, compound details, compound name, development stage (research-filed), geographical territory, potential deal size, upfront, total milestones-regulatory milestones-sales milestones payments, profit sharing, royalties on sales, research funding, equity and by year of deal establishment or any combination thereof.
Indications (selection)
Amylotrophic lateral slerosis (ALS), hereditary angioedema, immune thrombocytopenic purpura, multiple sclerosis, myasthenia gravis, osteoarthritis, psoriasis, rheumatoid arthritis, systemic lupus erythematosus (SLE)
Companies included in database
3S Bio, Abbott Laboratories (Kos Pharmaceuticals), Ablynx, Acorda Therapeutics, Actelion, Active Biotech, Agennix (GPC Biotech), Alder Biopharmaceuticals, Alizyme, Amarin Corporation, Amgen, Amorfix Life Sciences, Anaphore, Anika Therapeutics, Apitope Technology, Archemix Corporation, Argos Therapeutics, Astellas Pharma, Astralis Pharmaceuticals, AstraZeneca (MedImmune), Autoimmune, Bayer, BioCryst Pharmaceuticals, Biogen Idec (Biogen, Idec Pharmaceuticals), BioMarin Pharmaceutical, BioMS Medical Corporation, Bionomics, Biota Holdings (Biota Technology), Biotest, BioTie Therapeutics, Boehringer Ingelheim Pharma, Bristol-Myers Squibb, Can-Fite Biopharma, Catalyst Biosciences, Celera Corporation (Axys Pharmaceuticals), Cellzome, Cephalon, CGI Pharmaceuticals, Chelsea Therapeutics, CollaGenex Pharmaceuticals, Cosmo Pharmaceuticals (BioXell), Cypress Bioscience, Cytokine PharmaSciences (Cytokine Networks), Cytos Biotechnology, Dyax Corporation, Dynavax Technologies Corporation, Elan Corporation, Eli Lilly & Company, Emergent Biosolutions (Trubion Pharmaceuticals), Epix Pharmaceuticals (Predix Pharmaceuticals), Eusa Pharma, Exelixis, Facet Biotech Corporation (Protein Design Labs), Fernz Corporation (Pharma Pacific), Ferring Pharmaceuticals, Five Prime Therapeutics, Fresenius, Galapagos, Genmab, GlaxoSmithKline (Corixa, Coulter Pharmaceuticals, GeneLabs Technologies), Glenmark Pharmaceuticals, Halozyme Therapeutics, ILJIN Life Science Co., Immuno-Biological Laboratories, Immunomedics, ImmuPharma, Immutep, Incyte Corporation, Infinity Pharmaceuticals, Intellikine, Isotechnika, Johnson & Johnson (Centocor, Janssen Pharmaceutica), Karo Bio, Knopp Neurosciences, La Jolla Pharmaceutical Company, Leo Pharma, Ligand Pharmaceuticals (Pharmacopeia), MacroGenics, Maxygen, Medicis Pharmaceutical Corporation, MediGene (Avidex), Merck & Co (Schering-Plough), Merck Serono (Merck KGaA, Serono), Merrimack Pharmaceuticals, Micromet, Mitsubishi Tanabe Pharma, Multicell Technologies, Nektar Therapeutics (Inhale Therapeutic Systems), Norgine, Novartis, Novimmune, Novo Nordisk, Nycomed, Ono Pharmaceutical, Onyx Pharmaceuticals, Osiris Therapeutics, PAION (CeNeS Pharmaceuticals/Cambridge Neuroscience), Paratek Pharmaceuticals, Pfizer (Pharmacia Corporation, Warner-Lambert, Wyeth, Wyeth-Ayerst), Pharmacyclics, Pharming, Portola Pharmaceuticals, QuatRx Pharmaceuticals, Regeneron Pharmaceuticals, Regulus Therapeutics, Rigel Pharmaceuticals, Roche (Genentech), Sanofi (Genzyme Corporation (Biomatrix), Hoechst Marion Roussel, Rhone-Poulenc Rorer, Sanofi-Aventis), Santarus, Seikagaku Corporation, Shire (Jerini), Sigma-Tau (Defiante Farmaceutica), SkyePharma, Sunesis Pharmaceuticals, Taisho Pharmaceutical Co., TenX Biopharma, Teva Pharmaceutical Industries, ToleRx, TopoTarget, Toyama Chemical Co., UCB Pharma (Celltech), Vernalis (British Biotech), Vertex Pharmaceuticals, ViroPharma, Warner Chilcott (Galen Holdings), Watson Pharmaceuticals, Xencor, Xoma, YM Biosciences (Cytopia), Zenyaku Kogyo, Zymeworks, ZymoGenetics
